The HER2 amplicon includes several genes required for the growth and survival of HER2 positive breast cancer cells

About 20% of breast cancers are characterized by amplification and overexpression of the HER2 oncogene. Although significant progress has been achieved for treating such patients with HER2 inhibitor trastuzumab, more than half of the patients respond poorly or become resistant to the treatment. Sinc...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Oncol
Autors principals: Sahlberg, Kristine Kleivi, Hongisto, Vesa, Edgren, Henrik, Mäkelä, Rami, Hellström, Kirsi, Due, Eldri U., Moen Vollan, Hans Kristian, Sahlberg, Niko, Wolf, Maija, Børresen-Dale, Anne-Lise, Perälä, Merja, Kallioniemi, Olli
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2012
Matèries:
Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5528495/
https://ncbi.nlm.nih.gov/pubmed/23253899
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.molonc.2012.10.012
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars